|
Volumn 61, Issue 7, 2001, Pages 2809-2812
|
A light, nontoxic interleukin 12 protocol inhibits her-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia
a a b b a c d a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
GAMMA INTERFERON;
RECOMBINANT INTERLEUKIN 12;
ANGIOGENESIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BREAST CANCER;
BREAST CARCINOGENESIS;
CANCER INHIBITION;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DOSE RESPONSE;
FEMALE;
GENE OVEREXPRESSION;
HYPERPLASIA;
IMMUNE RESPONSE;
IMMUNOMODULATION;
MOUSE;
NONHUMAN;
ONCOGENE NEU;
PRIORITY JOURNAL;
TRANSGENIC MOUSE;
ANIMALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
GENES, ERBB-2;
HYPERPLASIA;
INTERFERON TYPE II;
INTERLEUKIN-12;
MAMMARY GLANDS, ANIMAL;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MICE;
MICE, TRANSGENIC;
|
EID: 0035300530
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (43)
|
References (20)
|